Malaria

Drug resistance and response

Efficacious antimalarial medicines are critical to malaria control and elimination. Continuous monitoring of their efficacy is needed to inform treatment policies in malaria-endemic countries, and to ensure early detection of, and response to, drug resistance. The emergence of multidrug resistance, including resistance to artemisinin and partner drugs, is a public health concern threatening the sustainability of the ongoing global effort to reduce the burden of malaria. The Global Technical Strategy for Malaria 2016–2030 calls on countries and global malaria partners to monitor the efficacy of antimalarial medicines so that the most appropriate treatments can be selected for national policies.


Antimalarial drug efficacy and drug resistance

Efficacious antimalarials are critical to malaria control, and continuous efficacy monitoring is needed to inform treatment policies and to ensure early detection of drug resistance.

Responding to antimalarial drug resistance

Protecting the efficacy of the recommended malaria treatments is a top priority for malaria endemic countries and the global malaria community.

Tools for monitoring antimalarial drug efficacy

Routine monitoring of antimalarial drug efficacy is necessary for effective case management and early detection of resistance.

Global database and maps

The global database on antimalarial drug efficacy and resistance centralizes data on the status of drug efficacy and drug resistance in malaria endemic countries.

Advisory committees on drug resistance and response

A standing Technical Expert Group (TEG) and 2 time-limited Evidence Review Group (ERG) have been convened to review the latest evidence and provide guidance and recommendations on drug resistance and containment.

Key resources

World malaria report 2017

This report contains the latest available data on malaria policies, interventions and trends in all endemic countries.

Contact us

Global Malaria Programme
World Health Organization
20 Avenue Appia
1211 Geneva 27
Switzerland
Tel: +41 22 791 2533
Fax: +41 22 791 4824
E-mail: infogmp@who.int